Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ, Gregg EW, Hu Y, Bennett PH, Li G; Da Qing Diabetes Prevention Study Group. Gong Q, et al. Among authors: bennett ph. Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. doi: 10.1016/S2213-8587(19)30093-2. Epub 2019 Apr 26. Lancet Diabetes Endocrinol. 2019. PMID: 31036503 Free PMC article.
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH. Li G, et al. Among authors: bennett ph. Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80. doi: 10.1016/S2213-8587(14)70057-9. Epub 2014 Apr 3. Lancet Diabetes Endocrinol. 2014. PMID: 24731674 Clinical Trial.
Authors' reply.
Li G, Zhang P, Gregg EW, Engelgau MM, Bennett PH. Li G, et al. Among authors: bennett ph. Lancet Diabetes Endocrinol. 2014 Jul;2(7):540. doi: 10.1016/S2213-8587(14)70131-7. Lancet Diabetes Endocrinol. 2014. PMID: 24999258 Free PMC article. No abstract available.
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen Y, Zhang P, Wang J, Gong Q, An Y, Qian X, Zhang B, Li H, Gregg EW, Bennett PH, Li G. Chen Y, et al. Among authors: bennett ph. Diabetologia. 2021 Jun;64(6):1279-1287. doi: 10.1007/s00125-021-05401-x. Epub 2021 Feb 19. Diabetologia. 2021. PMID: 33608769
Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
Gong Q, Zhang P, Wang J, Gregg EW, Cheng YJ, Li G, Bennett PH; Da Qing Diabetes Prevention Outcome Study Group. Gong Q, et al. Among authors: bennett ph. Diabetes Obes Metab. 2021 Oct;23(10):2385-2394. doi: 10.1111/dom.14481. Epub 2021 Jul 27. Diabetes Obes Metab. 2021. PMID: 34212465 Free PMC article.
427 results